Lonza Group, the global life sciences company, today announces an agreement with Cambrex Corporation (NYSE: CBM) to purchase its Research Bioproducts business and its Microbial Biopharmaceutical business for a cash consideration of US$ 460 million. In conjunction with the planned Initial Public Offering of Polynt S.p.A., these acquisitions will accelerate the group’s strategic development and […]
HERCULES, CA – October 16, 2006 – Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the acquisition of Blackhawk BioSystems, Inc., a San Ramon, California, based manufacturer of quality control products for use in laboratories that perform […]
Companies Will Provide Integrated Customer and Technical Support to Canadian Customers LA JOLLA, Calif.–Stratagene Corporation (NASDAQ:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostics products, announced today that VWR International, Inc. will become a distributor of Stratagene’s full line of research products in Canada. The companies expect that customers will be […]
September 21, 2006 – Takara Bio, Inc. (Shiga, Japan) announced today that they have entered into a license agreement with Applied Biosystems Group, an Applera Corporation business, under the expanded Applied Biosystems PCR (polymerase chain reaction) licensing program. The expanded program includes patents for real-time PCR and other important PCR-related technologies not licensed under the […]
CORALVILLE, Iowa–Sept. 18, 2006–Integrated DNA Technologies (IDT), a world leader in oligonucleotide production for life science research, today announced the acquisition of RNA-TEC, based in Leuven, Belgium. The acquisition broadens IDT’s capabilities in the specialized large-scale RNA synthesis and purification areas and adds RNA-TEC’s talented team, led by Dr. Brian Sproat, to IDT’s strong pool […]
BIOWIRE2K FOSTER CITY, Calif.–Sept. 5, 2006–Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, today announced that it has entered into a settlement agreement with Promega Corporation resolving outstanding legal disputes between the two companies. The terms of the settlement were not disclosed.
BIOWIRE2K CARLSBAD, Calif.–Sept. 1, 2006–Invitrogen Corporation (Nasdaq:IVGN), a global leader in life sciences, and Sentigen Holding Corp. (Nasdaq:SGHL) today announced that they had entered into a definitive merger agreement under which Invitrogen will acquire New Jersey-based Sentigen in a cash transaction at a price of $3.37 per share, or approximately $25.9 million for all shares […]
SAN JOSE, Calif., Sept. 1 — Applied Imaging Corp. (“Applied Imaging” or the “Company”) (OTC Bulletin Board: AICX), a leading supplier of automated imaging and image analysis systems, today announced that it had entered into a definitive agreement to be acquired by Genetix Group plc. (“Genetix”) (AIM: GTX), the UK-based cell biology, proteomics & genomics […]
PALO ALTO, Calif., Aug. 30, 2006 — Agilent Technologies Inc. (NYSE: A) today announced it has obtained worldwide, non-exclusive patent licenses from Abbott Molecular Inc. for the manufacture, marketing and sale of oligonucleotide microarrays using a two-or-more color technology for gene expression and comparative genomic hybridization (CGH) applications. This broad license covers microarray applications, including […]
BIOWIRE2K LA JOLLA, Calif.–Aug. 14, 2006–Stratagene Corporation (Nasdaq:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostics products, announced today that it has entered into a joint development and license agreement with Rosetta Inpharmatics LLC, a wholly-owned subsidiary of Merck & Co., Inc., to create an automated solution for the isolation of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
